Trial | NCT01619436  Report issue

Title

The Effect of Clonidine in Glycemia During Coronary Artery Bypass Graft With Cardiopulmonary By-pass
The Effect of Clonidine in Glycemia During Coronary Artery Bypass Graft With Cardiopulmonary By-pass.

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    46
The purpose of this study is the randomized blind research of the assessment of the different levels of glycemia during Coronary Artery Bypass Graft (CABG) with cardiopulmonary by-pass (CPB) between clonidine and placebo. As clonidine decrease the inflammatory response during cardiac surgery, the investigators would like to know if the glycemia levels in clondine group will be lower than placebo group.
Study Started
Jan 31
2011
Primary Completion
Jan 31
2012
Study Completion
May 31
2012
Last Update
Jun 14
2012
Estimate

Drug Clonidine

bolus, clonidine 2 mg/kg IV

Drug Ringer lactato

1 ML ringer lactato IV, as placebo

clonidine Active Comparator

clonidine 2 mg/kg IV

ringer lactato 1 ml Placebo Comparator

Ringer lactato 1 ml IV as Placebo

Criteria 

Inclusion Criteria:

elective CABG EF > 40% Sinus ritmy

Exclusion Criteria:

precordialgia emergency surgery combinated surgery not agreement
No Results Posted